Cargando…

Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach

INTRODUCTION: Genetic testing for hereditary cancer syndromes (HCSs) can improve health outcomes through cancer risk mitigation strategies. Effective communication between tested individuals and their family members is key to reducing the hereditary cancer burden. Our objective was to develop a pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollard, Samantha, Weymann, Deirdre, Loewen, Rosalie, Nuk, Jennifer, Sun, Sophie, Schrader, Kasmintan A., Hessels, Chiquita, Regier, Dean A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010078/ https://www.ncbi.nlm.nih.gov/pubmed/36660874 http://dx.doi.org/10.1111/hex.13702

Ejemplares similares

Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication
por: Pollard, Samantha, et al.
Publicado: (2020)

Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System
por: Richardson, Matthew, et al.
Publicado: (2020)

The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers
por: Weymann, Deirdre, et al.
Publicado: (2017)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
por: Cremin, Carol, et al.
Publicado: (2020)

Matching methods in precision oncology: An introduction and illustrative example
por: Weymann, Deirdre, et al.
Publicado: (2020)

Genetic matching for time-dependent treatments: a longitudinal extension and simulation study
por: Weymann, Deirdre, et al.
Publicado: (2023)

Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care
por: Weymann, Deirdre, et al.
Publicado: (2021)

Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment
por: Weymann, Deirdre, et al.
Publicado: (2018)

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers
por: Weymann, Deirdre, et al.
Publicado: (2021)

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
por: Regier, Dean A., et al.
Publicado: (2022)

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values
por: Costa, Sarah, et al.
Publicado: (2020)

“Game Changer”: Health Professionals’ Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management
por: Shickh, Salma, et al.
Publicado: (2022)

Hereditary diffuse gastric cancer: association with lobular breast cancer
por: Schrader, Kasmintan A., et al.
Publicado: (2007)

Portal Vein Thrombosis in a Patient with Hereditary Antithrombin Deficiency
por: Setaka, Tamao, et al.
Publicado: (2019)

Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing
por: Thibodeau, My Linh, et al.
Publicado: (2020)

Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology
por: Pollard, Samantha, et al.
Publicado: (2022)

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?
por: Pollard, Samantha, et al.
Publicado: (2021)

Assessment of SLX4 Mutations in Hereditary Breast Cancers
por: Shah, Sohela, et al.
Publicado: (2013)

Hereditary cancer genes are highly susceptible to splicing mutations
por: Rhine, Christy L., et al.
Publicado: (2018)

Workforce Implications of Increased Referrals to Hereditary Cancer Services in Canada: A Scenario-Based Analysis
por: Dragojlovic, Nick, et al.
Publicado: (2023)

Patient Portal Use Among Diabetic Patients With Different Races and Ethnicities
por: Wang, Hao, et al.
Publicado: (2022)

Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
por: Farncombe, Kirsten M., et al.
Publicado: (2023)

Perspectives of Patients About Immediate Access to Test Results Through an Online Patient Portal
por: Steitz, Bryan D., et al.
Publicado: (2023)

Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
por: Quezada Urban, Rosalía, et al.
Publicado: (2018)

How do patients and physicians communicate about hereditary angioedema in the United States?
por: Jain, Gagan, et al.
Publicado: (2021)

Portals to Wonderland: Health portals lead to confusing information about the effects of health care
por: Glenton, Claire, et al.
Publicado: (2005)

CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
por: Cremin, Carol, et al.
Publicado: (2018)

Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension
por: Bertoli, Luigi F., et al.
Publicado: (2017)

Applying the framework for developing and evaluating complex interventions to increase family communication about hereditary cancer
por: Cragun, Deborah L., et al.
Publicado: (2023)

Severe Late Toxicity After Adjuvant Breast Radiotherapy in a Patient with a Germline Ataxia Telangiectasia Mutated Gene: Future Treatment Decisions
por: Dosani, Maryam, et al.
Publicado: (2017)

Hereditary Breast Cancer: The Era of New Susceptibility Genes
por: Apostolou, Paraskevi, et al.
Publicado: (2013)

Genetic susceptibility to hereditary non-medullary thyroid cancer
por: Kamani, Tina, et al.
Publicado: (2022)

Protein Susceptibility to Peroxidation by 4-Hydroxynonenal in Hereditary Hemochromatosis
por: Sánchez-Jaut, Sandra, et al.
Publicado: (2023)

Hereditary hemorrhagic telangiectasia involving portal venous system: A case report and review of the literature
por: Wu, Jun-Ling, et al.
Publicado: (2023)

Rare APC promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis
por: Dixon, Katherine, et al.
Publicado: (2021)

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60
por: Regier, Dean A., et al.
Publicado: (2022)

Languages Support Efficient Communication about the Environment: Words for Snow Revisited
por: Regier, Terry, et al.
Publicado: (2016)

qPortal: A platform for data-driven biomedical research
por: Mohr, Christopher, et al.
Publicado: (2018)

Acute Care Patient Portal Intervention: Portal Use and Patient Activation
por: Schnock, Kumiko O, et al.
Publicado: (2019)

Hereditary Gigantism-the biblical giant Goliath and his brothers
por: Donnelly, Deirdre E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b50ukc0db8s6i02jj0q0hb4ii9